CD274 and liver cancer: In the future, the upstream molecular mechanism of its inhibition of PD-L1 expression in liver cancer cells should be explored in more detail, and a large-scale population study should be conducted to explore the advantages and disadvantages of its single drug and combined targeted drugs in the treatment of liver cancer.